Exercise Program During Preoperative Chemotherapy to Improve Breast Cancer Treatment Outcomes The Neo-ACT Randomized Trial
Led by Karolinska Institutet · Updated on 2025-09-22
712
Participants Needed
13
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether adding physical exercise during neoadjuvant chemotherapy NACT can improve outcomes for patients with primary invasive breast cancer. This trial focuses on whether exercise can increase the rate of pathological complete response pCR, meaning no invasive tumor remains after chemotherapy. Secondary goals include evaluating cancer burden after treatment, tumor response through imaging, quality of life, physical activity levels, muscle strength, fitness, cognitive effects, treatment completion, and long-term sick leave. The study also explores how exercise may influence anti-tumor mechanisms.
Participants will be randomly assigned to one of two groups usual care with routine information about physical activity or a supervised exercise program during chemotherapy. The exercise group will engage in two 60-minute sessions weekly of high-intensity interval and strength training, supported by a personalized mobile app and local physiotherapists. The program starts with a moderate warm-up and is tailored to each patients fitness and perceived exertion, continuing from the start of chemotherapy until surgery, about five months.
Throughout the study, participants will be carefully monitored with questionnaires, physical tests, and device-based activity tracking. Assessments include quality of life surveys, physical activity reports, muscle strength tests, cognitive function scans, fitness evaluations, tumor imaging, chemotherapy completion rates, and sick leave data. The primary outcome, pathological complete response, is assessed around 5-6 months after starting chemotherapy. Follow-up and data collection continue for up to two years to evaluate long-term effects and safety.
CONDITIONS
Brief Title
Physical Exercise During Preoperative Chemotherapy for Breast Cancer
Research Team
J
Jana de Boniface
C
Cecilia Haddad Ringborg
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with primary invasive breast cancer cT1-T3 cN0-2
Full tumour biology available before initiation of neoadjuvant chemotherapy
Provided oral and written consent
Age 18 years or older
You will not qualify if you...
Pregnancy or breastfeeding
Bilateral invasive breast cancer
Musculoskeletal, neurological, respiratory, metabolic, or cardiovascular conditions preventing safe exercise
Currently performing equal to or more than 150 minutes of moderate to high intensity aerobic exercise and 2 sessions per week of moderate intensity resistance exercise
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - Approximately 5 months
Participants randomized to the exercise group complete two structured 60-minute physical training sessions per week during neoadjuvant chemotherapy until surgery, approximately five months.
Weekly visits for up to 20 weeks
Follow-up
Duration - Up to 2 years
Participants are monitored for health-related quality of life, physical activity levels, chemotherapy completion, cognitive function, and other outcomes up to 2 years after surgery.
Visits at 1 year and 2 years post-surgery
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Studying Key Non-coding RNAs and Their Interaction With Chromatin Remodeling in Breast Cancer Patients
Comparing 18F-FDG and 68Ga-FAPI-46 PET Scans in Women With ER-positive Breast Cancer
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Observational Study Comparing 3D and 2D Echocardiography for Early Heart Damage Detection in Patients Receiving Anthracyclines and HER2-Targeted Cancer Therapies
Study Comparing 3D-Printed Biodegradable Breast Implants, Traditional Breast-Conserving Surgery, and Silicone Implant Reconstruction for Breast Cancer Patients
Ultrahypofractionated 5-Session Whole Breast Radiotherapy with Boost versus Standard 15-Session Radiotherapy for Breast Cancer Patients with Unfavorable Characteristics
Phase II Study Comparing 5-Day vs. 9-Day Whole Breast Radiotherapy with Boost in Early-stage Breast Cancer
Evaluating 68Ga-FAPI PETCT for Checking Axillary Lymph Node Status After Neoadjuvant Therapy in Women with Breast Cancer
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial.
Jana de Boniface, Renske Altena, Cecilia Haddad Ringborg...